Special Order Products
Some patients have certain clinical needs that cannot be met by licensed medicinal products. The law allows the manufacture and supply of some unlicensed medicines (referred to here as ‘Special Order products’), subject to conditions, to meet the needs of these patients. Specials are manufactured in the UK by manufacturers who hold a Specials license issued by the MHRA.
The charts, maps and data on this page have been produced using ePACT.net and provide information about prescribing of Special Order products in general practice in England. The data does not include any Special Order Products processed as Unspecified Drug Code Discount Not Deducted (DND).
ePACT.net users should notice a significant decline in the number of items shown as Unspec Drug Code (DND) as the majority of unlicensed products will be captured using the appropriate record on the NHS database. Only products for which no record is held will be captured as Unspec Drug Code (DND).
The Special Order Products tag has been updated over time to incorporate more products. This means that data obtained from ePACT.net for a specific time period will differ from the same time period when obtained after the tag has been updated. To ensure that prescribing trends are demonstrated, when these charts and data are updated, the most current tag will apply across all time periods.
The data includes all NHS prescribing which have been dispensed in the community, excluding items prescribed by dentists. From April 2015, items prescribed on FP10HP forms by hospitals will be included in this data.
Changes to Reimbursement of Special Order ProductsWith effect from November 2011 prescriptions, certain Special Order Products will be reimbursed according to Drug Tariff Part VIIIB Arrangements for Payment for Specials and Unlicensed Medicines. This means that certain products formerly categorised as Special Order Products will now be categorised as Drug Tariff Special Order Products. From the quarter to December 2011 updates, the charts and data will reflect these changes.
For further information and a list of products, please refer to the Drug Tariff Part VIIIB Arrangements for Payments for Specials and Unlicensed Medicines, or select the appropriate month at http://www.ppa.org.uk/ppa/edt_intro.htm
National level information
This National charts shows trends in prescribing and spending in the last 25 months.
National chart – Prescribing of and Spending on Special Order products (excel)
The spreadsheets below list the Top 500 Special Order products (by NIC and by items) from December 2011 to latest available quarterly data.
Top 500 Special Order products by NIC (excel)
Top 500 Special Order products by items (excel)
PCT/CCG level information
These CCG maps provide a comparison of prescribing and spending for the latest available quarterly data.
CCG maps – Prescribing of and Spending on Special Order products (pdf)
These CCG/Area Team charts provide a comparison of spending on Special Order products using the latest available quarterly data.
CCG/Area Team charts – Spending on Special Order products (excel)
The spreadsheet below shows PCT prescribing and spending from March 2011 – March 2013 (data from April 2013 has been restructured to CCG data).
PCT data – Prescribing of and Spending on Special Order products (excel)
The spreadsheet below shows CCG prescribing and spending for the latest available monthly data from April 2013.
CCG data – Prescribing of and Spending on Special Order products (excel)
The spreadsheet below provides a comparison of spending on Special Order products for the latest available quarterly data. CCGs are listed in descending order of cost (NIC) of Special Order products per 1,000 patients. Total NIC, total items, and NIC per Special Order item are also shown for each CCG.
CCG data – Comparison of spending on Special Order products (excel)